FDA Manufacturing Supplement Proposal To Be Discussed By Advisory Cmte.
This article was originally published in The Tan Sheet
Executive Summary
FDA's Pharmaceutical Sciences Advisory Committee will discuss the agency's proposal to reduce post-approval manufacturing change reporting requirements for "qualified " products during a Nov. 15-17 meeting.